EFFICACY OF THE DUPILUMAB 200 MG DOSE EVERY 2 WEEKS IN CHILDREN WITH MODERATE-TO-SEVERE ASTHMA DURING VOYAGE AND EXCURSION

被引：0
|
作者：
Phipatanakul, W. [1 ]
Vogelberg, C. [2 ]
LB, Bacharier [3 ]
Dell, S. D. [4 ]
Altincatal, A. [5 ]
Gall, R. [6 ]
Ledanois, O. [7 ]
Sacks, H. [6 ]
Jacob-Nara, J. A. [8 ]
Deniz, Y. [6 ]
Rowe, P. J. [8 ]
机构：
[1] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA
[2] Techn Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[3] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Med Ctr, Nashville, TN USA
[4] BC Childrens Hosp, Vancouver, BC, Canada
[5] Sanofi, Cambridge, MA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Paris, France
[8] Sanofi, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO26
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [41] DUPILUMAB EFFICACY IN UNCONTROLLED, MODERATE-TO-SEVERE ALLERGIC ASTHMA IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Castro, M.
    Corren, J.
    Hanania, N.
    Pavord, I.
    Quirce, S.
    Thangavelu, K.
    Rice, M.
    O'Riordan, T.
    Maroni, J.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S8 - S8
  • [42] Improved Lung Function Is Associated With Better Asthma Control in Children With Moderate-to-Severe Type 2 Asthma: Voyage Study
    Bacharier, L. B.
    Dell, S.
    De Mir-Messa, I.
    Piacentini, G.
    Hamelmann, E.
    Msihid, J.
    Gall, R.
    Ledanois, O.
    Wang, Z.
    Cheng, W.
    Sacks, H.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] DUPILUMAB EFFICACY IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND SEROLOGIC EVIDENCE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M.
    Deniz, Y.
    Rowe, P.
    Staudinger, H.
    Ruddy, M.
    Patel, N.
    Graham, N.
    Teper, A.
    Amin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S15 - S15
  • [44] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma with Elevated Type 2 Biomarkers and Fixed Airflow Obstruction
    Hanania, N. A.
    Castro, M.
    Bateman, E. D.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Daizadeh, N.
    Pandit-Abid, N.
    Ortiz, B.
    Laws, E.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Lederer, D. J.
    Hardin, M.
    Siddiqui, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [45] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma and Serologic Evidence of Allergic Bronchopulmonary Aspergillosis
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Staudinger, H. W.
    Ruddy, M.
    Patel, N.
    Graham, N. M. H.
    Teper, A.
    Amin, N.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [46] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
  • [47] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype: phase 2b dose-ranging study
    Quirce, S.
    Kuna, P.
    Hanania, N. A.
    Blaiss, M.
    Msihid, J.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P.
    Gall, R.
    Ortiz, B.
    Djandji, M.
    Radwan, A.
    ALLERGY, 2021, 76 : 10 - 11
  • [48] Late Breaking Abstract- Clinical remission with dupilumab in children with uncontrolled, moderate-to-severe, type 2 asthma
    Bacharier, Leonard
    Guilbert, Theresa W.
    Maspero, Jorge F.
    Gappa, Monika
    Dell, Sharon
    Altincatal, Arman
    Ledanois, Olivier
    Gall, Rebecca
    Sacks, Harry
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [49] Dupilumab Efficacy by Baseline Disease Severity Among Children With Uncontrolled Moderate-to-Severe Asthma: Post-hoc Results From the Randomized, Placebo-controlled VOYAGE Trial
    Jackson, D. J.
    Gappa, M.
    Bacharier, L. B.
    Deschildre, A.
    Ross, K. R.
    Xia, C.
    Gall, R.
    Ledanois, O.
    Jacob-Nara, J. A.
    Sacks, H. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [50] Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
    Peters, Anju T.
    Sagara, Hironori
    Corren, Jonathan
    Domingo, Christian
    Altincatal, Arman
    Soler, Xavier
    Pandit-Abid, Nami
    Crikelair, Nora
    Rowe, Paul J.
    Jacob-Nara, Juby A.
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (04) : 477 - 484.e4
12345